U.S. markets close in 4 hours 6 minutes
  • S&P 500

    3,859.05
    -41.06 (-1.05%)
     
  • Dow 30

    31,254.04
    -184.22 (-0.59%)
     
  • Nasdaq

    11,310.61
    -213.95 (-1.86%)
     
  • Russell 2000

    1,760.76
    -10.98 (-0.62%)
     
  • Crude Oil

    110.76
    +1.19 (+1.09%)
     
  • Gold

    1,822.10
    -2.70 (-0.15%)
     
  • Silver

    20.88
    -0.29 (-1.38%)
     
  • EUR/USD

    1.0539
    -0.0048 (-0.45%)
     
  • 10-Yr Bond

    3.2070
    +0.0130 (+0.41%)
     
  • GBP/USD

    1.2202
    -0.0068 (-0.56%)
     
  • USD/JPY

    136.2110
    +0.7650 (+0.56%)
     
  • BTC-USD

    20,660.45
    -131.96 (-0.63%)
     
  • CMC Crypto 200

    449.17
    -0.89 (-0.20%)
     
  • FTSE 100

    7,323.41
    +65.09 (+0.90%)
     
  • Nikkei 225

    27,049.47
    +178.20 (+0.66%)
     

MedAvail to Participate in Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

MISSISSAUGA, Ontario & PHOENIX, June 07, 2022--(BUSINESS WIRE)--(Nasdaq: MDVL)— MedAvail Holdings, Inc. ("MedAvail"), a technology-enabled retail pharmacy company, today announced that the company will be participating in the following virtual investor conferences.

  • Lytham Partners Summer 2022 Investor Conference
    Tuesday, June 21, 2022 to Wednesday, June 22, 2022
    Presentation available beginning on June 21, 2022, at 9:00 a.m. Eastern Time

  • Cowen 7th Annual FutureHealth Conference
    Fireside chat on Wednesday, June 22, 2022, at 10:50 a.m. Eastern Time

Interested parties may access the webcasts of these sessions on the "Investors" section of the company website at https://investors.medavail.com.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

SOURCE MedAvail Holdings, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220607006196/en/

Contacts

Investor Relations
Caroline Paul
Gilmartin Group
ir@medavail.com